These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35921025)

  • 21. Downregulation of cytokeratin 18 induces cellular partial EMT and stemness through increasing EpCAM expression in breast cancer.
    Shi R; Liu L; Wang F; He Y; Niu Y; Wang C; Zhang X; Zhang X; Zhang H; Chen M; Wang Y
    Cell Signal; 2020 Dec; 76():109810. PubMed ID: 33069797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer.
    Vijay GV; Zhao N; Den Hollander P; Toneff MJ; Joseph R; Pietila M; Taube JH; Sarkar TR; Ramirez-Pena E; Werden SJ; Shariati M; Gao R; Sobieski M; Stephan CC; Sphyris N; Miura N; Davies P; Chang JT; Soundararajan R; Rosen JM; Mani SA
    Breast Cancer Res; 2019 Mar; 21(1):37. PubMed ID: 30845991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hydroxytyrosol inhibits cancer stem cells and the metastatic capacity of triple-negative breast cancer cell lines by the simultaneous targeting of epithelial-to-mesenchymal transition, Wnt/β-catenin and TGFβ signaling pathways.
    Cruz-Lozano M; González-González A; Marchal JA; Muñoz-Muela E; Molina MP; Cara FE; Brown AM; García-Rivas G; Hernández-Brenes C; Lorente JA; Sanchez-Rovira P; Chang JC; Granados-Principal S
    Eur J Nutr; 2019 Dec; 58(8):3207-3219. PubMed ID: 30460610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CDKL2 promotes epithelial-mesenchymal transition and breast cancer progression.
    Li L; Liu C; Amato RJ; Chang JT; Du G; Li W
    Oncotarget; 2014 Nov; 5(21):10840-53. PubMed ID: 25333262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The epithelial-to-mesenchymal transition and cancer stem cells: a coalition against cancer therapies.
    Hollier BG; Evans K; Mani SA
    J Mammary Gland Biol Neoplasia; 2009 Mar; 14(1):29-43. PubMed ID: 19242781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heterogeneity and Plasticity of Breast Cancer Stem Cells.
    Sousa B; Ribeiro AS; Paredes J
    Adv Exp Med Biol; 2019; 1139():83-103. PubMed ID: 31134496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resistin induces breast cancer cells epithelial to mesenchymal transition (EMT) and stemness through both adenylyl cyclase-associated protein 1 (CAP1)-dependent and CAP1-independent mechanisms.
    Avtanski D; Garcia A; Caraballo B; Thangeswaran P; Marin S; Bianco J; Lavi A; Poretsky L
    Cytokine; 2019 Aug; 120():155-164. PubMed ID: 31085453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of microRNAs in the regulation of breast cancer stem cells.
    Liu S; Clouthier SG; Wicha MS
    J Mammary Gland Biol Neoplasia; 2012 Mar; 17(1):15-21. PubMed ID: 22331423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Doxorubicin-Resistant TNBC Cells Exhibit Rapid Growth with Cancer Stem Cell-like Properties and EMT Phenotype, Which Can Be Transferred to Parental Cells through Autocrine Signaling.
    Paramanantham A; Jung EJ; Kim HJ; Jeong BK; Jung JM; Kim GS; Chan HS; Lee WS
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pomegranate Extract Alters Breast Cancer Stem Cell Properties in Association with Inhibition of Epithelial-to-Mesenchymal Transition.
    Nallanthighal S; Elmaliki KM; Reliene R
    Nutr Cancer; 2017 Oct; 69(7):1088-1098. PubMed ID: 28976208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breast cancer stem cell: the roles and therapeutic implications.
    Yang F; Xu J; Tang L; Guan X
    Cell Mol Life Sci; 2017 Mar; 74(6):951-966. PubMed ID: 27530548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Keap1-Nrf2 Pathway Regulates ALDH and Contributes to Radioresistance in Breast Cancer Stem Cells.
    Kamble D; Mahajan M; Dhat R; Sitasawad S
    Cells; 2021 Jan; 10(1):. PubMed ID: 33419140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EMT in breast cancer stem cell generation.
    Ansieau S
    Cancer Lett; 2013 Sep; 338(1):63-8. PubMed ID: 22634497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breast cancer stem cells: Multiple capacities in tumor metastasis.
    Geng SQ; Alexandrou AT; Li JJ
    Cancer Lett; 2014 Jul; 349(1):1-7. PubMed ID: 24727284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer stem cells in solid and liquid tissues of breast cancer patients: characterization and therapeutic perspectives.
    Chiotaki R; Polioudaki H; Theodoropoulos PA
    Curr Cancer Drug Targets; 2015; 15(3):256-69. PubMed ID: 25669721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epithelial-to-mesenchymal transition and cancer stem cells contribute to breast cancer heterogeneity.
    Hong D; Fritz AJ; Zaidi SK; van Wijnen AJ; Nickerson JA; Imbalzano AN; Lian JB; Stein JL; Stein GS
    J Cell Physiol; 2018 Dec; 233(12):9136-9144. PubMed ID: 29968906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reprogramming during epithelial to mesenchymal transition under the control of TGFβ.
    Tan EJ; Olsson AK; Moustakas A
    Cell Adh Migr; 2015; 9(3):233-46. PubMed ID: 25482613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-221/222 promote cancer stem-like cell properties and tumor growth of breast cancer via targeting PTEN and sustained Akt/NF-κB/COX-2 activation.
    Li B; Lu Y; Yu L; Han X; Wang H; Mao J; Shen J; Wang B; Tang J; Li C; Song B
    Chem Biol Interact; 2017 Nov; 277():33-42. PubMed ID: 28844858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The epithelial-mesenchymal transition and cancer stem cells: functional and mechanistic links.
    Liu X; Fan D
    Curr Pharm Des; 2015; 21(10):1279-91. PubMed ID: 25506898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Basal/HER2 breast carcinomas: integrating molecular taxonomy with cancer stem cell dynamics to predict primary resistance to trastuzumab (Herceptin).
    Martin-Castillo B; Oliveras-Ferraros C; Vazquez-Martin A; Cufí S; Moreno JM; Corominas-Faja B; Urruticoechea A; Martín ÁG; López-Bonet E; Menendez JA
    Cell Cycle; 2013 Jan; 12(2):225-45. PubMed ID: 23255137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.